NO921025L - Fremgangsmaate for fremstilling og anvendelse av blandede pyridin-2,4- og 2,5-dikarboksylsyrediamider, anvendelse avde samme, samt legemidler paa basis av forbindelsene - Google Patents

Fremgangsmaate for fremstilling og anvendelse av blandede pyridin-2,4- og 2,5-dikarboksylsyrediamider, anvendelse avde samme, samt legemidler paa basis av forbindelsene

Info

Publication number
NO921025L
NO921025L NO92921025A NO921025A NO921025L NO 921025 L NO921025 L NO 921025L NO 92921025 A NO92921025 A NO 92921025A NO 921025 A NO921025 A NO 921025A NO 921025 L NO921025 L NO 921025L
Authority
NO
Norway
Prior art keywords
compounds
dicarboxylic acid
diamids
procedure
preparation
Prior art date
Application number
NO92921025A
Other languages
English (en)
Other versions
NO178859B (no
NO921025D0 (no
NO178859C (no
Inventor
Ekkehard Baader
Martin Bickel
Volkmar Guenzler-Pukall
Manfred Volz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO921025D0 publication Critical patent/NO921025D0/no
Publication of NO921025L publication Critical patent/NO921025L/no
Publication of NO178859B publication Critical patent/NO178859B/no
Publication of NO178859C publication Critical patent/NO178859C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO921025A 1991-03-18 1992-03-17 Pyridin-2,4- og 2,5-dikarboksylsyrediamider og anvendelse av de samme, samt legemidler på basis av disse forbindelsene NO178859C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4108824 1991-03-18

Publications (4)

Publication Number Publication Date
NO921025D0 NO921025D0 (no) 1992-03-17
NO921025L true NO921025L (no) 1992-09-21
NO178859B NO178859B (no) 1996-03-11
NO178859C NO178859C (no) 1996-06-19

Family

ID=6427597

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921025A NO178859C (no) 1991-03-18 1992-03-17 Pyridin-2,4- og 2,5-dikarboksylsyrediamider og anvendelse av de samme, samt legemidler på basis av disse forbindelsene

Country Status (22)

Country Link
EP (1) EP0504799B1 (no)
JP (1) JP3121428B2 (no)
KR (1) KR100243959B1 (no)
AT (1) ATE154929T1 (no)
AU (1) AU645668B2 (no)
CA (1) CA2063177A1 (no)
CZ (1) CZ282298B6 (no)
DE (1) DE59208651D1 (no)
DK (1) DK0504799T3 (no)
ES (1) ES2104758T3 (no)
FI (1) FI101701B (no)
GR (1) GR3024309T3 (no)
HR (1) HRP940835A2 (no)
HU (1) HU217809B (no)
IE (1) IE920843A1 (no)
IL (1) IL101257A (no)
MX (1) MX9201156A (no)
NO (1) NO178859C (no)
NZ (1) NZ241968A (no)
TW (1) TW199147B (no)
YU (1) YU48156B (no)
ZA (1) ZA921945B (no)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
ATE113036T1 (de) * 1988-08-04 1994-11-15 Hoechst Ag Verbessertes verfahren zur herstellung von n,n- bis(alkoxyalkyl)-pyridin -2,4- dicarbonsäurediamiden.
DE3924093A1 (de) * 1989-07-20 1991-02-07 Hoechst Ag N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE3928144A1 (de) * 1989-08-25 1991-02-28 Hoechst Ag Zyklische pyridin-2,4- und -2,5-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE3938805A1 (de) * 1989-11-23 1991-05-29 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE4030999A1 (de) * 1990-10-01 1992-04-09 Hoechst Ag 4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel

Also Published As

Publication number Publication date
KR100243959B1 (ko) 2000-03-02
DE59208651D1 (de) 1997-08-07
TW199147B (no) 1993-02-01
NZ241968A (en) 1994-04-27
JPH0586032A (ja) 1993-04-06
EP0504799A1 (de) 1992-09-23
HU9200891D0 (en) 1992-05-28
GR3024309T3 (en) 1997-10-31
JP3121428B2 (ja) 2000-12-25
ATE154929T1 (de) 1997-07-15
CA2063177A1 (en) 1992-09-19
YU24692A (sh) 1994-06-24
HU217809B (hu) 2000-04-28
CZ282298B6 (cs) 1997-06-11
CS80392A3 (en) 1992-10-14
FI921119A0 (fi) 1992-03-16
FI101701B1 (fi) 1998-08-14
DK0504799T3 (da) 1998-02-02
MX9201156A (es) 1992-10-01
HRP940835A2 (en) 1997-06-30
YU48156B (sh) 1997-05-28
KR920018051A (ko) 1992-10-21
NO178859B (no) 1996-03-11
NO921025D0 (no) 1992-03-17
FI921119A (fi) 1992-09-19
IL101257A (en) 1998-03-10
ES2104758T3 (es) 1997-10-16
IL101257A0 (en) 1992-11-15
ZA921945B (en) 1992-11-25
AU1296792A (en) 1992-09-24
NO178859C (no) 1996-06-19
EP0504799B1 (de) 1997-07-02
FI101701B (fi) 1998-08-14
IE920843A1 (en) 1992-09-23
AU645668B2 (en) 1994-01-20
HUT62565A (en) 1993-05-28

Similar Documents

Publication Publication Date Title
PT81058A (de) Ester der pyridin-2,4- und -2,5-dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase
NO940789L (no) Quinolinkarboksylsyrederivater, deres fremstilling og anvendelse
IL109144A (en) Glycoprotein IIB/IIIA inhibiting 4-pyridylamino heterocyclic derivatives process for their preparation and pharmaceutical compositions containing them
NO880558D0 (no) Pyridin-2,4- og 2,5-dikarboksylsyreamider, samt fremgangsmaate for fremstilling derav.
ATE196135T1 (de) Pyridoncarbonsäurederivate
NO880556L (no) Pyridin-2,4- og 2,5-dikarboksylsyrederivater, samt fremgangsmaater for fremstilling av forbindelsene.
NO921025D0 (no) Fremgangsmaate for fremstilling og anvendelse av blandede pyridin-2,4- og 2,5-dikarboksylsyrediamider, anvendelse avde samme, samt legemidler paa basis av forbindelsene
DK0409119T3 (da) N,N-Bis(alkoxyalkyl)-pyridin-2,4-dicarboxylsyrediamider, fremgangsmåde til deres fremstilling samt deres anvendelse
NO910163D0 (no) Fremgangsmaate for fremstilling og anvendelse av pyridin-2,4- og 2,5-dikarboksylsyredi-(nitroksyalkyl)amid.
DE69300376D1 (de) Verfahren zur Herstellung von 2,3-Pyridindicarbonsäuren aus 3-(2-Imidazolin-2-Yl)Picolinsäuren.
DK0491140T3 (da) Fremgangsmåde til fremstilling af substituerede og usubstituerede 2,3-pyridin- og -quinolincarboxylsyrer
EP0430029A3 (en) Pyridin-2,4- and 2,5-dicarboxylic acid diamides, process for their preparation and their use
IL100860A0 (en) 2,4-and 2,5-bistetrazolylpyridines,a process for the preparation thereof and the use thereof as pharmaceuticals
DK0548522T3 (da) Fremgangsmåde til rensning af 2,3-pyridin- og -quinolindicarboxylsyrediesterforbindelser

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2002